These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23386289)

  • 21. Chronic granulomatous disease.
    Heyworth PG; Cross AR; Curnutte JT
    Curr Opin Immunol; 2003 Oct; 15(5):578-84. PubMed ID: 14499268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid determination of chimerism status using dihydrorhodamine assay in a patient with X-linked chronic granulomatous disease following hematopoietic stem cell transplantation.
    Kim HY; Kim HJ; Ki CS; Kim DW; Yoo KH; Kang ES
    Ann Lab Med; 2013 Jul; 33(4):288-92. PubMed ID: 23826567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation at histidine 338 of gp91(phox) depletes FAD and affects expression of cytochrome b558 of the human NADPH oxidase.
    Yoshida LS; Saruta F; Yoshikawa K; Tatsuzawa O; Tsunawaki S
    J Biol Chem; 1998 Oct; 273(43):27879-86. PubMed ID: 9774399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease.
    Roesler J; Curnutte JT; Rae J; Barrett D; Patino P; Chanock SJ; Goerlach A
    Blood; 2000 Mar; 95(6):2150-6. PubMed ID: 10706888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients].
    Nunoi H; Ishibashi F
    Rinsho Byori; 1999 Jul; 47(7):658-64. PubMed ID: 10442045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox.
    Porter CD; Parkar MH; Verhoeven AJ; Levinsky RJ; Collins MK; Kinnon C
    Blood; 1994 Oct; 84(8):2767-75. PubMed ID: 7919388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
    Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
    Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
    Bionda C; Li XJ; van Bruggen R; Eppink M; Roos D; Morel F; Stasia MJ
    Hum Genet; 2004 Oct; 115(5):418-27. PubMed ID: 15338276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes.
    Geiszt M; Lekstrom K; Brenner S; Hewitt SM; Dana R; Malech HL; Leto TL
    J Immunol; 2003 Jul; 171(1):299-306. PubMed ID: 12817011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADPH oxidase.
    Noack D; Rae J; Cross AR; Muñoz J; Salmen S; Mendoza JA; Rossi N; Curnutte JT; Heyworth PG
    Hum Genet; 1999 Nov; 105(5):460-7. PubMed ID: 10598813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two breakthroughs in CGD studies].
    Nunoi H
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Feb; 30(1):1-10. PubMed ID: 17332699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
    Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
    J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody 7D5 recognizes the R147 epitope on the gp91
    Kawai C; Yamauchi A; Kuribayashi F
    Microbiol Immunol; 2018 Apr; 62(4):269-280. PubMed ID: 29573449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
    Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
    Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation.
    Anderson-Cohen M; Holland SM; Kuhns DB; Fleisher TA; Ding L; Brenner S; Malech HL; Roesler J
    Clin Immunol; 2003 Dec; 109(3):308-17. PubMed ID: 14697745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9-generated p47
    Wrona D; Siler U; Reichenbach J
    Sci Rep; 2017 Mar; 7():44187. PubMed ID: 28287132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity.
    Jendrossek V; Ritzel A; Neubauer B; Heyden S; Gahr M
    Eur J Haematol; 1997 Feb; 58(2):78-85. PubMed ID: 9111587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
    Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
    Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second Report of Chronic Granulomatous Disease in Jordan: Clinical and Genetic Description of 31 Patients From 21 Different Families, Including Families From Lybia and Iraq.
    Bakri FG; Mollin M; Beaumel S; Vigne B; Roux-Buisson N; Al-Wahadneh AM; Alzyoud RM; Hayajneh WA; Daoud AK; Shukair MEA; Karadshe MF; Sarhan MM; Al-Ramahi JAW; Fauré J; Rendu J; Stasia MJ
    Front Immunol; 2021; 12():639226. PubMed ID: 33746979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T cell features in chronic granulomatous disease.
    van de Geer A; Cuadrado E; Slot MC; van Bruggen R; Amsen D; Kuijpers TW
    Clin Exp Immunol; 2019 Aug; 197(2):222-229. PubMed ID: 30924925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.